

Health Care: Drugs
China-biotics Inc. (CHBT: OTC)
$2.45 0.26 | 11.87%
05/24/13 - 03:57 PM ET
14.64K / 776.60K
Vol / Avg. Vol:
2.19 / 2.19
Open / Prev. Close:
2.15 - 2.45
Today's Range:
Portfolios with CHBT
Latest CHBT Headlines from TheStreet
More Financial News for CHBT
Press Releases for CHBT
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In China-Biotics, Inc. To Contact The Firm - PR Newswire 06.01.12 | 07:06 pm
- Bronstein, Gewirtz & Grossman, LLC Investigates China-Biotics, Inc. - Business Wire 07.01.11 | 11:07 am
- China-Biotics, Inc. Receives NASDAQ Delisting Notification - PR Newswire 06.23.11 | 05:06 pm
- China-Biotics Provides Update - PR Newswire 06.16.11 | 03:06 pm
- Finkelstein Thompson LLP Announces Investigation Of China-Biotics, Inc. - Business Wire 10.18.10 | 06:10 pm
- The Rosen Law Firm Files Class Action Lawsuit Charging China-Biotics, Inc. With Securities Fraud--CHBT - Business Wire 09.17.10 | 08:09 pm
- Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of China-Biotics, Inc. - Business Wire 09.16.10 | 08:09 pm
- The Law Office Of Robbins Umeda LLP Announces An Investigation Of China-Biotics, Inc. - Business Wire 09.14.10 | 08:09 pm
- Ryan & Maniskas, LLP Announces An Investigation Of China-Biotics, Inc. - Business Wire 09.14.10 | 07:09 pm
- Investor Notice: The Rosen Law Firm Announces Investigation Of Shareholder Securities Claims Against China-Biotics --- CHBT - Business Wire 09.03.10 | 08:09 pm
See All Press Releases
Partner Headlines for CHBT